All Biological drugs articles
-
ResearchEncapsulated bacteria show promise as injectable living drugs factories to treat diseases
Engineered E. coli produce insulin and vaccines in vivo
-
BusinessUS finalises guidance on biosimilars
Regulator clarifies requirements for allowing substitution between products
-
-
ArticleHow biologics have changed the rules for pharma
The impact of the latest generation of drugs for the healthcare industry
-
-
ResearchNanodecoys lure and trap Zika virus
Gelatin nanoparticles camouflaged by mosquito membrane mop up virus and stop it crossing placenta
-
ArticleThe ever-increasing attraction of biologics
Biologics promise targeted treatments for a range of conditions – if we can overcome the technological challenges
-
FeatureFrom venoms to medicine
Venoms are a treasure trove of peptides that may provide a bounty of novel painkillers
-
OpinionRise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
BusinessIndia probes Roche over biosimilars
Mylan and Biocon claim Roche abused its market dominance to quash generic breast cancer antibodies
-
FeatureIntracellular delivery
Drugs that can enter cells and take useful payloads with them are maturing, finds Andy Extance
-
BusinessChemical firms seek better grasp of biomanufacturing
The search is on for better alternatives to the ‘broken’ way companies harness compound-making organisms
-
Business
Roche backs biologics boom
Swiss firm to invest heavily in manufacturing for complex biological drugs
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe
-
Business
Bapineuzunab dropped
Development for the Alzheimer’s treatment stopped after clinical tests